Skip to main content

Milestone Pharmaceuticals Inc.

MIST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001408443

No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Milestone Pharmaceuticals Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
43
+4 vs. Q2 2024
Shares held
28.7M
+3.47M (+13.8%) vs. Q2 2024
Total value
$43.6M
+$10.3M (+30.8%) vs. Q2 2024
New holders
5
9 more added
Sold out
1
9 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 43 institutions
Q1 2021: 34 institutionsQ2 2021: 28 institutionsQ3 2021: 27 institutionsQ4 2021: 28 institutionsQ1 2022: 28 institutionsQ2 2022: 29 institutionsQ3 2022: 47 institutionsQ4 2022: 56 institutionsQ1 2023: 50 institutionsQ2 2023: 48 institutionsQ3 2023: 39 institutionsQ4 2023: 40 institutionsQ1 2024: 43 institutionsQ2 2024: 40 institutionsQ3 2024: 43 institutionsQ4 2024: 47 institutionsQ1 2025: 43 institutionsQ2 2025: 43 institutionsQ3 2025: 61 institutionsQ4 2025: 80 institutionsQ1 2026: 87 institutionsQ2 2026: 78 institutions
Value heldQ3 2024: $43.6M
Q1 2021: $117.4MQ2 2021: $110.8MQ3 2021: $113.9MQ4 2021: $132.6MQ1 2022: $135.1MQ2 2022: $127.2MQ3 2022: $198.7MQ4 2022: $96.9MQ1 2023: $85.5MQ2 2023: $59.0MQ3 2023: $60.7MQ4 2023: $29.7MQ1 2024: $56.4MQ2 2024: $39.9MQ3 2024: $43.6MQ4 2024: $57.9MQ1 2025: $9.46MQ2 2025: $22.9MQ3 2025: $68.3MQ4 2025: $70.7MQ1 2026: $47.2MQ2 2026: $66.4M
Institutions holding MIST and their total value by quarter
QuarterHoldersValue
Q2 202678$66.4M
Q1 202687$47.2M
Q4 202580$70.7M
Q3 202561$68.3M
Q2 202543$22.9M
Q1 202543$9.46M
Q4 202447$57.9M
Q3 202443$43.6M
Q2 202440$39.9M
Q1 202443$56.4M
Q4 202340$29.7M
Q3 202339$60.7M
Q2 202348$59.0M
Q1 202350$85.5M
Q4 202256$96.9M
Q3 202247$198.7M
Q2 202229$127.2M
Q1 202228$135.1M
Q4 202128$132.6M
Q3 202127$113.9M
Q2 202128$110.8M
Q1 202134$117.4M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q2 2024.

Institutions holding MIST in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Simplex Trading, LLC214$00.00%−977−82.0%Reduced
Barclays PLC100$1520.00%00.0%Unchanged
Oliver Lagore Vanvalin Investment Group100$1520.00%00.0%Unchanged
Royal Bank of Canada800$1.00K0.00%+800New
Jones Financial Companies LLLP1,000$1.53K0.00%−70−6.5%Reduced
Advisor Group Holdings, Inc.6,500$9.88K0.00%00.0%Unchanged
National Bank of Canada7,100$10.8K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec10,500$16.0K0.00%00.0%Unchanged
Engineers Gate Manager LP11,074$16.8K0.00%+11,074New
Creative Planning13,080$19.9K0.00%00.0%Unchanged
Beta Wealth Group, Inc.14,127$21.5K0.01%00.0%Unchanged
Geode Capital Management, LLC17,576$26.7K0.00%00.0%Unchanged
State Street Corp19,311$29.4K0.00%+388+2.1%Added
Clear Creek Financial Management, LLC19,500$29.6K0.00%00.0%Unchanged
Valeo Financial Advisors, LLC20,000$30.4K0.00%+10,000+100.0%Added
Two Sigma Securities, LLC23,133$35.2K0.00%+23,133New
Cetera Investment Advisers24,671$37.5K0.00%+3,982+19.2%Added
Northern Trust Corp27,336$41.5K0.00%−448−1.6%Reduced
ADAR1 Capital Management, LLC27,931$42.5K0.01%−174,529−86.2%Reduced
BNP Paribas Arbitrage, SA29,209$44.4K0.00%+4,609+18.7%Added
PVG Asset Management Corp30,345$46.1K0.19%+30,345New
Boothbay Fund Management, LLC30,779$46.8K0.00%00.0%Unchanged
Dimensional Fund Advisors LP39,450$60.0K0.00%00.0%Unchanged
Atria Investments LLC40,421$61.4K0.00%+12,430+44.4%Added
Squarepoint Ops LLC54,245$82.5K0.00%−439−0.8%Reduced
Ancora Advisors, LLC60,000$91.2K0.00%00.0%Unchanged
Envestnet Asset Management Inc70,590$107.3K0.00%+11,067+18.6%Added
Boxer Capital, LLC309,007$469.7K0.02%00.0%Unchanged
Altium Capital Management LP440,000$668.8K0.20%−572,368−56.5%Reduced
Ikarian Capital, LLC466,019$708.3K0.22%00.0%Unchanged
Morgan Stanley918,312$1.40M0.00%+89,658+10.8%Added
Stonepine Capital Management, LLC999,790$1.52M0.96%−239,409−19.3%Reduced
BML Capital Management, LLC1,136,091$1.73M1.02%+33,196+3.0%Added
Bleichroeder LP1,326,085$2.02M0.54%00.0%Unchanged
Goldman Sachs Group Inc1,353,067$2.06M0.00%00.0%Unchanged
Lion Point Capital, LP1,654,154$2.51M10.09%−686,053−29.3%Reduced
Nantahala Capital Management, LLC1,750,000$2.66M0.22%00.0%Unchanged
OrbiMed Advisors LLC2,000,000$3.04M0.06%00.0%Unchanged
Citadel Advisors LLC2,061,522$3.13M0.00%−85,822−4.0%Reduced
Alta Fundamental Advisers LLC2,658,589$4.04M1.67%00.0%Unchanged
Millennium Management LLC2,778,525$4.22M0.00%+28,595+1.0%Added
RTW Investments, LP3,256,102$4.95M0.07%00.0%Unchanged
BlackRock, Inc.4,971,344$7.56M0.00%+4,971,344New
Qube Research & Technologies Ltd0$00.00%−194−100.0%Sold out
BlackRock Inc.––––Not filed